Hemoglobinopathies
Showing 1 - 25 of 138
Sickle Cell Hemoglobinopathies and Bone Health
Active, not recruiting
- Sickle Cell Disease
- Sickle Cell Trait
- Healthy volunteers without SCT
- +2 more
-
Farmington, ConnecticutUConn Health
Nov 1, 2022
Study of the Role of Genetic Modifiers in Hemoglobinopathies
Recruiting
- Sickle Cell Disease
- +3 more
- GWAS
-
Boston, Massachusetts
- +24 more
Apr 4, 2023
Hemoglobinopathies, Thalassemia, Sickle Cell Disease Trial in Banha (Hemoglobinopathy Nursing Program)
Completed
- Hemoglobinopathies
- +3 more
- Hemoglobinopathy Nursing Program
-
Banhā, Other, EgyptBenha University
May 21, 2022
Hemoglobinopathies and Rare Inherited Anemia and Covid 19
Recruiting
- Haemoglobinopathies
-
Genova, Italy
- +1 more
May 4, 2022
Alpha Thalassemia Hemoglobin H Constant Spring, Hemoglobinopathies, Hereditary Diseases Trial in Nanning (RM-004)
Recruiting
- Alpha Thalassemia Hemoglobin H Constant Spring
- +2 more
- RM-004
-
Nanning, Guangxi, ChinaThe 923rd Hospital of Joint Logistics Support Force of People's
Oct 25, 2023
Screening for Hemoglobinopathies in Pregnant Women
Recruiting
- Hemoglobinopathies
- Review of routine lab data
-
Basel, SwitzerlandFrauenklinik University Hospital Basel
Oct 13, 2021
Total Splenectomy vs Partial Splenectomy in Non-malignant
Not yet recruiting
- Splenectomy; Status
-
Montpellier, FranceUniversity hospital of Montpellier
Dec 22, 2021
Alpha Thalassemia Major, Hemoglobinopathy; With Thalassemia, Hemoglobinopathies Trial in San Francisco (in utero hematopoietic
Enrolling by invitation
- Alpha Thalassemia Major
- +8 more
- in utero hematopoietic stem cell transplantation
-
San Francisco, CaliforniaUniversity of California
Oct 28, 2022
Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Nashville (CTX001)
Recruiting
- Beta-Thalassemia
- +4 more
- CTX001
-
Nashville, Tennessee
- +5 more
Feb 2, 2023
Sickle Cell Disease, Hydroxyurea Failure, Hydroxyurea Intolerance Trial in Nashville (CTX001)
Recruiting
- Sickle Cell Disease
- +4 more
- CTX001
-
Philadelphia, Pennsylvania
- +3 more
Jan 24, 2023
Sickle Cell Disease, Hemoglobinopathies Trial in Nashville (drug, procedure, radiation)
Active, not recruiting
- Sickle Cell Disease
- Hemoglobinopathies
- Thymoglobulin
- +7 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Dec 20, 2021
Women With Heterozygous Hemoglobinopathies
Completed
- Heterozygous Haemoglobinopathy
- pregnancy outcome
-
Basel, Switzerland
- +1 more
Jun 30, 2021
Non Malignant Diseases, Immunodeficiencies, Hemoglobinopathies Trial in Philadelphia (RIC: Distal Campath, RIC:Intermediate
Recruiting
- Non Malignant Diseases
- +2 more
- RIC: Distal Campath
- +2 more
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Mar 8, 2022
Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major Trial in Nashville (EDIT-301)
Recruiting
- Transfusion Dependent Beta Thalassemia
- +3 more
- EDIT-301
-
Oakland, California
- +3 more
Jan 3, 2023
Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)
Not yet recruiting
- Beta-Thalassemia
- +6 more
- CTX001
- (no location specified)
Jul 26, 2022
STUDY INCIDENCE AND CHARACTERISTICS OF MALIGNANT NEOPLASIES IN
Recruiting
- Malignacy, Hemoglobinopathie
-
Cagliari, ItalyAzienda Ospedaliera Universitaria Di Cagliari
Mar 18, 2022
AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)
Recruiting
- AML
- +8 more
- Clofarabine
- +5 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 13, 2022
Oxidative Stress and Iron Overload in Abnormal Haemoglobinopathy
Not yet recruiting
- Oxidative Stress in Patient With Haemoglobinopathy and Affect it of Endocrine System
- (no location specified)
Oct 16, 2022
Sickle Cell Disease, Beta Thalassemia-Major Trial in New Hyde Park (alemtuzumab (Campath IH), Fludarabine, Melphalan)
Completed
- Sickle Cell Disease
- Beta Thalassemia-Major
- alemtuzumab (Campath IH)
- +6 more
-
New Hyde Park, New YorkCohen Children's Medical Center of New York
Jul 30, 2021
Hemoglobinopathies Trial (transcranial doppler)
Not yet recruiting
- Hemoglobinopathies
- transcranial doppler
- (no location specified)
Mar 12, 2021
Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem
Active, not recruiting
- Hematologic Malignancies
- +7 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 28, 2022
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)
Not yet recruiting
- Acute Lymphoblastic Leukemia in Remission
- +10 more
- CliniMACS
-
Houston, Texas
- +1 more
Dec 8, 2022
Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit
Recruiting
- Sickle Cell Disease
- +4 more
- Cyclophosphamide
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 6, 2022
Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)
Active, not recruiting
- Beta-Thalassemia
- +4 more
- CTX001
-
Stanford, California
- +11 more
Nov 30, 2022
Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders Trial in New Haven, Saint Louis (RIC regimen,
Recruiting
- Severe Sickle Cell Disease
- +5 more
- RIC regimen
- GVHD prophylaxis regimen
-
New Haven, Connecticut
- +1 more
Feb 4, 2022